DK348575A - Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner - Google Patents

Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner

Info

Publication number
DK348575A
DK348575A DK348575A DK348575A DK348575A DK 348575 A DK348575 A DK 348575A DK 348575 A DK348575 A DK 348575A DK 348575 A DK348575 A DK 348575A DK 348575 A DK348575 A DK 348575A
Authority
DK
Denmark
Prior art keywords
dehydro
trihydroxy
prostaglandins
procedure
preparation
Prior art date
Application number
DK348575A
Other languages
Danish (da)
English (en)
Inventor
C Gandolfi
G Doria
R Pellegata
M M Usardi
Original Assignee
Erba C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba C filed Critical Erba C
Publication of DK348575A publication Critical patent/DK348575A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK348575A 1974-09-17 1975-07-31 Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner DK348575A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2733374 1974-09-17

Publications (1)

Publication Number Publication Date
DK348575A true DK348575A (da) 1976-03-18

Family

ID=11221442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK348575A DK348575A (da) 1974-09-17 1975-07-31 Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner

Country Status (20)

Country Link
US (1) US4041064A (fr)
JP (1) JPS5929075B2 (fr)
BE (1) BE832891A (fr)
CA (1) CA1098126A (fr)
CH (2) CH614936A5 (fr)
CS (1) CS191274B2 (fr)
DE (1) DE2537406A1 (fr)
DK (1) DK348575A (fr)
FI (1) FI752303A (fr)
FR (1) FR2313028A1 (fr)
GB (2) GB1514542A (fr)
HK (1) HK4079A (fr)
HU (1) HU175345B (fr)
IL (1) IL48027A (fr)
MY (1) MY8000016A (fr)
NL (1) NL7510191A (fr)
NO (1) NO150117C (fr)
SE (2) SE423992B (fr)
SU (1) SU942588A3 (fr)
ZA (1) ZA755310B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220759A (en) * 1975-03-14 1980-09-02 Carlo Erba S.P.A. 13,14-Dehydro-11-deoxy-prostaglandins and process for their preparation
HU178202B (en) * 1977-09-26 1982-03-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new,optically active and racemic bicyclic acetals and merkaptals
WO2007041273A2 (fr) * 2005-09-29 2007-04-12 Eastar Chemical Corp. Procédé de production d'intermédiaires pour la synthèse de dérivés de prostaglandines tels que latanoprost, travaprost, and bimatoprost

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones

Also Published As

Publication number Publication date
CH617424A5 (fr) 1980-05-30
GB1514543A (en) 1978-06-14
SE427556B (sv) 1983-04-18
FI752303A (fr) 1976-03-18
HK4079A (en) 1979-01-26
FR2313028B1 (fr) 1980-05-30
NO752675L (fr) 1976-03-18
US4041064A (en) 1977-08-09
SU942588A3 (ru) 1982-07-07
CS191274B2 (en) 1979-06-29
SE7808849L (sv) 1978-08-22
ZA755310B (en) 1977-04-27
FR2313028A1 (fr) 1976-12-31
JPS5929075B2 (ja) 1984-07-18
MY8000016A (en) 1980-12-31
IL48027A (en) 1980-03-31
CH614936A5 (fr) 1979-12-28
HU175345B (hu) 1980-07-28
NO150117C (no) 1984-08-22
SE423992B (sv) 1982-06-21
GB1514542A (en) 1978-06-14
IL48027A0 (en) 1975-11-25
CA1098126A (fr) 1981-03-24
NO150117B (no) 1984-05-14
DE2537406A1 (de) 1976-08-12
JPS5143745A (en) 1976-04-14
SE7509607L (sv) 1976-03-18
NL7510191A (nl) 1976-03-19
BE832891A (fr) 1976-03-01
AU8350075A (en) 1977-02-03

Similar Documents

Publication Publication Date Title
DK397575A (da) Fremgangsmade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner
DK138501C (da) Analogifremgangsmaade til fremstilling af 3alfa-hydroxy-d-homo-5alfa-pregnan-11,20-dioner
DK144298C (da) Fremgangsmaade til fremstilling af alkyl-tert-butylethere
DK490775A (da) Fremgangsmade til fremstilling af eventuelt substituerede 1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-oner
DK385475A (da) Fremgangsmade til fremstilling af secoprostaglandiner
DK179675A (da) Fremgangsmade til fremstilling af 6-amino-5-r3-2,4-diaminopyrimidin-3-oxider
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK141849C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK547475A (da) Fremgangsmade til fremstilling af 8,8-disubstituerede 6-methylergoliner
DK136729C (da) Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner
DK206375A (da) Fremgangsmade til fremstilling af thiaprostaglandiner
DK574075A (da) Fremgangsmade til fremstilling af 2-methoxybenzamider
DK390975A (da) Fremgangsmade til fremstilling af omega-nor-cycloalkyl-13,14-dehydroprostaglandiner
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
DK543875A (da) Fremgangsmade til fremstilling af hydroxyphenylacetonitriler
DK528475A (da) Fremgangsmade til fremstilling af tetramethylethylendiamin
DK583775A (da) Fremgangsmade til fremstilling af 3-fluorbenzodiazepiner
DK496275A (da) Fremgangsmade til fremstilling af 1,2,3,4-tetrahydroisoquinoliner
DK137539C (da) Fremgangsmaade til fremstilling af 11beta-fluor-4-androsten-3-oner
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK593575A (da) Fremgangsmade til fremstilling af trichlorethylchlorformiat
DK132661C (da) Fremgangsmade til fremstilling af 17-acylestere af 17alfa,21-dihydroxysteroider af pregnanrekken
DK352975A (da) Fremgangsmade til fremstilling af 3beta-(4-oxoalfa-l-rhamnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid
DK137721C (da) Fremgangsmaade til fremstilling af alfa-oxothiodimethylamider
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment